Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Haynes

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Recent Progress in Hormone Research|January 30, 2004
Leptin and the cardiovascular systemKamal Rahmouni, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2007
LDL cholesteryl oleate: a biomarker for atherosclerosis?Arthur A Spector, William G Haynes
Journal of Hypertension|August 27, 2002
Pharmacotherapy of obesity: lessons from clinical trials in hypertensionWilliam G Haynes, Allyn L Mark
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 4, 2011
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsGraziela Z Kalil, William G Haynes
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 2, 2002
Role of endothelin in cardiovascular diseaseAlexei V Agapitov, William G Haynes
Cleveland Clinic Journal of Medicine|October 14, 2004
Homocysteine: is it a clinically important cardiovascular risk factor?Steven R Lentz, William G Haynes
Current Psychiatry|November 4, 2014
Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa?Jess G Fiedorowicz, William G Haynes
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelinesMarcelo L G Correia, William G Haynes
The Surgical Clinics of North America|August 3, 2005
Dietary and medical therapy of obesityPhyllis Stumbo, Donna Hemingway, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?Marcelo L G Correia, William G Haynes
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Recent Progress in Hormone Research|January 30, 2004
Leptin and the cardiovascular systemKamal Rahmouni, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2007
LDL cholesteryl oleate: a biomarker for atherosclerosis?Arthur A Spector, William G Haynes
Journal of Hypertension|August 27, 2002
Pharmacotherapy of obesity: lessons from clinical trials in hypertensionWilliam G Haynes, Allyn L Mark
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 4, 2011
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsGraziela Z Kalil, William G Haynes
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 2, 2002
Role of endothelin in cardiovascular diseaseAlexei V Agapitov, William G Haynes
Cleveland Clinic Journal of Medicine|October 14, 2004
Homocysteine: is it a clinically important cardiovascular risk factor?Steven R Lentz, William G Haynes
Current Psychiatry|November 4, 2014
Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa?Jess G Fiedorowicz, William G Haynes
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelinesMarcelo L G Correia, William G Haynes
The Surgical Clinics of North America|August 3, 2005
Dietary and medical therapy of obesityPhyllis Stumbo, Donna Hemingway, William G Haynes
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2006
A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?Marcelo L G Correia, William G Haynes
Pageof 9